Stroke and stroke-like symptoms in patients with mutations in the POLG1 gene

Journal of Inherited Metabolic Disease

Volumn 1, Issue , 2011, Pages 89-96

  Brinjikji, Waleed ^a   Swanson, Jerry W ^b   Dyck, Peter J ^b   Tracy, Jennifer A ^b   Zabel, Carrie ^b   Gavrilova, Ralitza H ^b  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Mitochondrial; POLG1; Stroke

Indexed keywords

EID: 84895561094     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/8904_2011_22     Document Type: Article

References (24)

1. Alpers BJ (1931) Diffuse progressive degeneration of the grey matter of the cerebrum. Arch Neurol Psychiatry 25:469–505
2. Blok MJ, van den Bosch BJ, Jongen E et al (2009) The unfoldingclinical spectrum of POLG mutations. J Med Genet 46:776–785
3. Chan SS, Longley MJ, Copeland WC (2005a) The common A467Tmutation in the human mitochondrial DNA polymerase (POLG) compromises catalytic efficiency and interaction with the accessory subunit. J BiolChem 280:31341–31346
4. Chan SS, Longley MJ, Naviaux RK, Copeland WC (2005b) Monoallelic POLG expression resulting from missense-mediated decay and alternative splicing in a patient with Alpers syndrome. DNA Repair 4:1381–1389
5. Del Zotto E, Pezzini A, Giossi A, Volonghi I, Padovani A (2008) Migraine and ischemic stroke: a debated question. J Cereb Blood Flow Metab 28:1399–1421
6. Deschauer M, Tennant S, Rokicka A et al (2007) MELAS associatedwith mutations in the POLG1 gene. Neurology 68:1741–1742
7. Hopkins SE, Somoza A, Gilbert DL (2010) Rare autosomal dominantPOLG1 mutation in a family with metabolic strokes, posterior column spinal degeneration, and multi-endocrine disease. J Child Neurol 25:752–756
8. Horvath R, Hudson G, Ferrari G et al (2006) Phenotypic spectrum associated with mutations of the mitochondrial polymerasegamma gene. Brain 129:1674–1684
9. Koga Y, Ishibashi M, Ueki I et al (2002) Effects of L-arginine on the acute phase of strokes in three patients with MELAS. Neurology58:827–828
10. Koga Y, Akita Y, Nishioka J et al (2005) L-arginine improves the symptoms of stroke like episodes in MELAS. Neurology 64:710–712
11. Koga Y, Akita Y, Junko N et al (2006) Endothelial dysfunction in MELAS improved by l-arginine supplementation. Neurology 66:1766–1769
12. Koga Y, Akita Y, Nishioka J et al (2007) MELAS and L-argininetherapy. Mitochondrion 7:133–139
13. Kollberg G, Moslemi AR, Darin N et al (2006) POLG1 mutationsassociated with progressive encephalopathy in childhood. J Neuropathol Exp Neurol 65:758–768
14. Luoma PT, Luo N, Loscher WN et al (2005) Functional defects due tospacer-region mutations of human mitochondrial DNA polymerase in a family with an ataxia-myopathy syndrome. Hum Mol Genet14:1907–1920
15. Milone M, Massie R (2010) Polymerase gamma 1 mutations: clinicalcorrelations. Neurologist 16:84–91
16. Montine TJ, Powers JM, Vogel FS, Radtke RA (1995) Alpers’ syndrome presenting with seizures and multiple stroke-like episodes in a 17-year-old male. Clin Neuropathol 14:322–326
17. Naviaux RK, Nyhan WL, Barshop BA, Poulton J, Markusic D, Karpinski NC, Haas RH (1999) Mitochondrial DNA Polymerase gamma Deficiency and mtDNA Depletion in a Child with Alpers’ Syndrome. Ann Neurol 45:54–58
18. Naviaux RK, Nguyen KV (2004) POLG mutations associated with Alpers’ syndrome and mitochondrial DNA depletion. Ann Neurol 55:706–712
19. Rahman S, Hanna MG (2009) Diagnosis and therapy in neuro muscular disorders: diagnosis and new treatments in mitochondrial diseases. J Neurol Neurosurg Psychiatry 80:943–953
20. Spector JT, Kahn SR, Jones MR, Jayakumar M, Dalal D, Nazarian S (2010) Migraine headache and ischemic stroke risk: an updated meta-analysis. Am J Med 123:612–624
21. Stewart JD, Tennant S, Powell H et al (2009) Novel POLG1 mutations associated with neuromuscular and liver phenotypes in adults and children. J Med Genet 46:209–214
22. Tzoulis C, Engelsen BA, Telstad W et al (2006) The spectrum of clinical disease caused by the A467T and W748S POLG mutations: a study of 26 cases. Brain 14:1685–1692
23. Van Goethem G, Dermaut B, Lofgren A, Martin JJ, Van Broeckhoven C (2001) Mutation of POLG is associated with progressive externalophthalmoplegia characterized by mtDNA deletions. Nat Genet28:211–212
24. Wong LJ, Naviaux RK, Brunetti-Pierri N et al (2008) Molecular and clinical genetics of mitochondrial diseases due to POLG mutations. Hum Mutat 29:E150–E172